{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:08:22Z","timestamp":1790467702428,"version":"4.1.0"},"reference-count":167,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system in which environmental factors play an important role in shaping disease risk, activity, and progression. Over the past decade, human and experimental studies have consistently shown alterations in the gut microbiome across the phenotypic spectrum of MS and have linked these changes to immune dysregulation, barrier dysfunction, neuroinflammation, and demyelination. Additionally, emerging evidence indicates that microbial function, particularly metabolite production plays a more direct role in shaping immune responses and associated neuropathology. Evidence from both human studies and experimental autoimmune encephalomyelitis models supports a functional role for microbial metabolites in shaping neuroimmune responses. Bacterially derived metabolites such as short-chain fatty acids, bile acids, polyamines, phytoestrogen metabolites, and tryptophan-derived compounds can influence T-cell differentiation, glial activation, epithelial integrity, and neuroimmune communication. Recent longitudinal studies also show associations between metabolite profiles and disability worsening. Because disease-modifying therapies, diet, and microbiome-directed interventions can reshape microbial metabolism, microbial metabolites may represent promising therapeutic targets in the gut-immune-brain axis. In this\n                    <jats:italic>Review<\/jats:italic>\n                    , we integrate current evidence to propose a mechanistic framework in which microbial metabolites act as central regulators of mucosal and systemic immunity that influence different aspects of MS biology. We discuss how this perspective shifts gut microbiome research from descriptive associations to biological mechanisms that more directly link the gut to immune responses and downstream neuropathology. We then evaluate therapeutic strategies that target microbial metabolism and outline key priorities for longitudinal, multi-omics, and interventional studies that are needed to enable microbiome-informed precision therapies in MS.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1858047","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:13:52Z","timestamp":1782893632000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Gut microbiota and gut-derived metabolites in defining multiple sclerosis phenotypic continuum"],"prefix":"10.3389","volume":"17","author":[{"given":"Federico","family":"Montini","sequence":"first","affiliation":[{"name":"Department of Neurology, Mayo Clinic","place":["Rochester, MN, United States"]},{"name":"Mayo Clinic Center for Multiple Sclerosis and Autoimmune Neurology","place":["Rochester, MN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh","family":"Mangalam","sequence":"additional","affiliation":[{"name":"Department of Pathology, Carver College of Medicine, University of Iowa","place":["Iowa City, IA, United States"]},{"name":"Iowa City Veterans Affairs Health Care System","place":["Iowa City, IA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcu","family":"Zeydan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic","place":["Rochester, MN, United States"]},{"name":"Mayo Clinic Center for Multiple Sclerosis and Autoimmune Neurology","place":["Rochester, MN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Murray","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic","place":["Rochester, MN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orhun H.","family":"Kantarci","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic","place":["Rochester, MN, United States"]},{"name":"Mayo Clinic Center for Multiple Sclerosis and Autoimmune Neurology","place":["Rochester, MN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2018.01.021","article-title":"Multiple sclerosis: mechanisms and immunotherapy","volume":"97","author":"Baecher-Allan","year":"2018","journal-title":"Neuron"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awag158","article-title":"The cascade to pathogenicity in autoantibody-mediated CNS diseases","author":"Montini","year":"2026","journal-title":"Brain: A J Neurol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102028","article-title":"Microbiota-produced immune regulatory bile acid metabolites control central nervous system autoimmunity","volume":"6","author":"Antonini Cencicchio","year":"2025","journal-title":"Cell Rep Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1700492","article-title":"High frequency of intestinal T(H)17 cells correlates with microbiota alterations and disease activity in multiple sclerosis","volume":"3","author":"Cosorich","year":"2017","journal-title":"Sci Adv"},{"key":"B5","doi-asserted-by":"publisher","first-page":"102055","DOI":"10.2139\/ssrn.4886559","article-title":"Gut microbiota and metabolites are linked to disease progression in multiple sclerosis","volume":"6","author":"Schwerdtfeger","year":"2025","journal-title":"Cell Rep Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/srep28484","article-title":"Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12015","article-title":"Alterations of the human gut microbiome in multiple sclerosis","volume":"7","author":"Jangi","year":"2016","journal-title":"Nat Commun"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137429","article-title":"Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to Clostridia XIVa and IV clusters","volume":"10","author":"Miyake","year":"2015","journal-title":"PloS One"},{"key":"B9","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12883-016-0703-3","article-title":"Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls","volume":"16","author":"Tremlett","year":"2016","journal-title":"BMC Neurol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"16396","DOI":"10.1038\/s41598-019-52894-z","article-title":"Gut microbiome of treatment-naive MS patients of different ethnicities early in disease course","volume":"9","author":"Ventura","year":"2019","journal-title":"Sci Rep"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/bf02100148","article-title":"Multiple sclerosis patients have peripheral blood CD45RO+ B cells and increased intestinal permeability","volume":"41","author":"Yacyshyn","year":"1996","journal-title":"Dig Dis Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i37.4217","article-title":"Focus on the gut-brain axis: multiple sclerosis, the intestinal barrier and the microbiome","volume":"24","author":"Camara-Lemarroy","year":"2018","journal-title":"World J Gastroenterol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105721","article-title":"Faecal mucoprotein MUC2 is decreased in multiple sclerosis and is associated with mucin degrading bacteria","volume":"116","author":"Schwerdtfeger","year":"2025","journal-title":"EBioMedicine"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1207617","article-title":"Aging in multiple sclerosis: from childhood to old age, etiopathogenesis, and unmet needs: a narrative review","volume":"14","author":"Capasso","year":"2023","journal-title":"Front Neurol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-021-05442-5","article-title":"Stress related to COVID-19 pandemic as a trigger for disease activity in multiple sclerosis: a case report","volume":"42","author":"Giordano","year":"2021","journal-title":"Neurological Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-021-05472-z","article-title":"Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) after SARS-CoV-2 pneumonia","volume":"42","author":"Montini","year":"2021","journal-title":"Neurological Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000202393","article-title":"Modifiable risk factors of COVID-19 in patients with multiple sclerosis: a single-centre case-control study","volume":"270","author":"Montini","year":"2023","journal-title":"J Neurol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2023-332073","article-title":"COVID-19 has no impact on disease activity, progression and cognitive performance in people with multiple sclerosis: a 2-year study","volume":"95","author":"Montini","year":"2024","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/b978-0-323-95702-1.00153-6","article-title":"The innate immune system in CNS diseases; overview","author":"Montini","year":"2024"},{"key":"B20","doi-asserted-by":"publisher","first-page":"28505","DOI":"10.1038\/s41598-025-13262-2","article-title":"Gut microbiota distinguishes aging hispanics with Alzheimer's disease: associations with cognitive impairment and severity","volume":"15","author":"Sep\u00falveda-Rivera","year":"2025","journal-title":"Sci Rep"},{"key":"B21","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.chom.2023.01.004","article-title":"Deficient butyrate-producing capacity in the gut microbiome is associated with bacterial network disturbances and fatigue symptoms in ME\/CFS","volume":"31","author":"Guo","year":"2023","journal-title":"Cell Host Microbe"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105959","article-title":"Alterations of the nasal and oral microbiota in multiple sclerosis","volume":"121","author":"Li","year":"2025","journal-title":"eBioMedicine"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-021-00488-4","article-title":"The role of oral bacteria in inflammatory bowel disease","volume":"18","author":"Read","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awy069","article-title":"T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention","volume":"141","author":"van Langelaar","year":"2018","journal-title":"Brain"},{"key":"B25","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12866-019-1685-2","article-title":"Primary progressive multiple sclerosis in a Russian cohort: relationship with gut bacterial diversity","volume":"19","author":"Kozhieva","year":"2019","journal-title":"BMC Microbiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51004","article-title":"Gut microbiome variation is associated to multiple sclerosis phenotypic subtypes","volume":"7","author":"Reynders","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2011703117","article-title":"Alterations of the gut ecological and functional microenvironment in different stages of multiple sclerosis","volume":"117","author":"Takewaki","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26084","article-title":"Gut microbiome in progressive multiple sclerosis","volume":"89","author":"Cox","year":"2021","journal-title":"Ann Neurol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.08.058","article-title":"Th17 cell induction by adhesion of microbes to intestinal epithelial cells","volume":"163","author":"Atarashi","year":"2015","journal-title":"Cell"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1016\/j.cell.2022.08.021","article-title":"Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course","volume":"185","year":"2022","journal-title":"Cell"},{"key":"B31","doi-asserted-by":"publisher","first-page":"15292","DOI":"10.1038\/s41598-024-64369-x","article-title":"Identification of commensal gut microbiota signatures as predictors of clinical severity and disease progression in multiple sclerosis","volume":"14","author":"Montgomery","year":"2024","journal-title":"Sci Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2413953122","article-title":"Specific microbial ratio in the gut microbiome is associated with multiple sclerosis","volume":"122","author":"Ghimire","year":"2025","journal-title":"Proc Natl Acad Sci USA"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2419689122","article-title":"Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice\u2014An unbiased functional study","volume":"122","author":"Yoon","year":"2025","journal-title":"Proc Natl Acad Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12974-025-03417-3","article-title":"Akkermansia mono-colonization modulates microglia and astrocytes in a strain specific manner","volume":"22","author":"Schwerdtfeger","year":"2025","journal-title":"J Neuroinflamm"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1711235114","article-title":"Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models","volume":"114","author":"Cekanaviciute","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4415\/ANN_16_02_12","article-title":"Sex-based differences in autoimmune diseases","volume":"52","author":"Ortona","year":"2016","journal-title":"Ann Ist Super Sanita"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000316802.35974.34","article-title":"Temporal trends in the incidence of multiple sclerosis: a systematic review","volume":"71","author":"Alonso","year":"2008","journal-title":"Neurology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/b978-008088783-8.00070-x","article-title":"Sex differences in autoimmune diseases","volume":"2","author":"Voskuhl","year":"2011","journal-title":"Biol Sex Differ"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-13-128","article-title":"Incidence and prevalence of multiple sclerosis in Europe: a systematic review","volume":"13","author":"Kingwell","year":"2013","journal-title":"BMC Neurol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2025.578589","article-title":"Effects of androgen modifying therapies on disease activity in older men with multiple sclerosis","volume":"403","author":"Zeydan","year":"2025","journal-title":"J\u00a0Neuroimmunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaa185","article-title":"Reproductive history and progressive multiple sclerosis risk in women","volume":"2","author":"Zeydan","year":"2020","journal-title":"Brain Commun"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1177\/13524585241311441","article-title":"Upper cervical spinal cord atrophy in MS: sex, menopause, and neurodegeneration","volume":"31","author":"Zeydan","year":"2025","journal-title":"Mult Scler"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-018-0723-8","article-title":"Sex differences in autoimmune disorders of the central nervous system","volume":"41","author":"Gold","year":"2019","journal-title":"Semin Immunopathol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1530\/rep-22-0303","article-title":"Sex, puberty, and the gut microbiome","volume":"165","author":"Sisk-Hackworth","year":"2023","journal-title":"Reproduction"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1186\/s13317-021-00149-1","article-title":"Short-chain fatty acids and intestinal inflammation in multiple sclerosis: modulation of female susceptibility by microbial products","volume":"12","author":"Becker","year":"2021","journal-title":"Auto Immun Highlights"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1101\/343558","article-title":"Multiple sclerosis-associated changes in the composition and immune functions of spore-forming bacteria","volume":"3","author":"Cekanaviciute","year":"2018","journal-title":"mSystems"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000000517","article-title":"Disease-modifying therapies alter gut microbial composition in MS","volume":"6","author":"Katz Sand","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1514762","article-title":"The gut-brain-axis one year after treatment with cladribine tablets in patients with relapsing remitting multiple sclerosis: a pilot study","volume":"16","author":"van Pamelen","year":"2025","journal-title":"Front Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1038\/s41598-022-07336-8","article-title":"B-cell-depletion reverses dysbiosis of the microbiome in multiple sclerosis patients","volume":"12","author":"Troci","year":"2022","journal-title":"Sci Rep"},{"key":"B50","doi-asserted-by":"publisher","first-page":"153ra131","DOI":"10.1126\/scitranslmed.3004186","article-title":"An RNA profile identifies two subsets of multiple sclerosis patients differing in disease activity","volume":"4","author":"Ottoboni","year":"2012","journal-title":"Sci Transl Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.035","article-title":"Propionic acid shapes the multiple sclerosis disease course by an immunomodulatory mechanism","volume":"180","author":"Duscha","year":"2020","journal-title":"Cell"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3758\/s13423-017-1410-9","article-title":"Inhibition of Escherichia coli by dimethyl fumarate","volume":"65","author":"Wang","year":"2001","journal-title":"Int J Food Microbiol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2017.00011","article-title":"Oral multiple sclerosis drugs inhibit the in vitro growth of epsilon toxin producing gut bacterium, Clostridium perfringens","volume":"7","author":"Rumah","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01794-15","article-title":"Fumarate-mediated persistence of Escherichia coli against antibiotics","volume":"60","author":"Kim","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2147055","article-title":"Gut microbiota composition as a candidate risk factor for dimethyl fumarate-induced lymphopenia in multiple sclerosis","volume":"14","author":"Diebold","year":"2022","journal-title":"Gut Microbes"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1177\/2055217319888767","article-title":"Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis - a pilot trial","volume":"5","author":"Storm-Larsen","year":"2019","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000200466","article-title":"Stool glial fibrillary acidic protein is elevated in progressive multiple sclerosis","volume":"12","author":"Schwerdtfeger","year":"2025","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B59","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.1212\/wnl.0000000000211415","article-title":"Alterations in the gut microbiome and gut mucus levels are associated with 7T MRI leptomeningeal enhancement and cortical lesions in MS (P11-1.016)","volume":"104","author":"Montini","year":"2025","journal-title":"Neurology"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa043335","article-title":"Natalizumab induction and maintenance therapy for Crohn's disease","volume":"353","author":"Sandborn","year":"2005","journal-title":"N Engl J Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21716","article-title":"Natalizumab to kill two birds with one stone: a case of celiac disease and multiple sclerosis","volume":"17","author":"Phan-Ba","year":"2011","journal-title":"Inflammation Bowel Dis"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2023.103053","article-title":"HNF4\u03b1, SP1 and c-myc are master regulators of CNS autoimmunity","volume":"138","author":"Colombo","year":"2023","journal-title":"J Autoimmun"},{"key":"B63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-031-84065-4_1","article-title":"The intestine is an important hub for development and regulation of innate and adaptive immunity","volume-title":"Physical and Biological Barriers at the Interface Between the Gut Microbiome and the Immune System","author":"Lo Conte","year":"2025"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1436717","article-title":"Circulating MAIT cells in multiple sclerosis and amyotrophic lateral sclerosis","volume":"15","author":"De Federicis","year":"2024","journal-title":"Front Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2024.07.039","article-title":"Machine learning-driven diagnosis of multiple sclerosis from whole blood transcriptomics","volume":"121","author":"Omrani","year":"2024","journal-title":"Brain Behavior Immun"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.4103\/2319-4170.130922","article-title":"Mammalian gut immunity","volume":"37","author":"Chassaing","year":"2014","journal-title":"BioMed J"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.09.007","article-title":"Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine","volume":"43","author":"Haghikia","year":"2015","journal-title":"Immunity"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1000082107","article-title":"Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis","author":"Lee","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"B69","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1016\/j.cell.2021.11.018","article-title":"Stem-like intestinal Th17 cells give rise to pathogenic effector T cells during autoimmunity","volume":"184","author":"Schnell","year":"2021","journal-title":"Cell"},{"key":"B70","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.celrep.2019.09.002","article-title":"Disrupting myelin-specific Th17 cell gut homing confers protection in an adoptive transfer experimental autoimmune encephalomyelitis","volume":"29","author":"Duc","year":"2019","journal-title":"Cell Rep"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aaz6563","article-title":"IL-17 controls central nervous system autoimmunity through the intestinal microbiome","volume":"6","author":"Regen","year":"2021","journal-title":"Sci Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11639","article-title":"Gut environment-induced intraepithelial autoreactive CD4(+) T cells suppress central nervous system autoimmunity via LAG-3","volume":"7","author":"Kadowaki","year":"2016","journal-title":"Nat Commun"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz012","article-title":"Gut microbiota-dependent CCR9+CD4+ T cells are altered in secondary progressive multiple sclerosis","volume":"142","author":"Kadowaki","year":"2019","journal-title":"Brain"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abc7191","article-title":"Gut microbiota-specific IgA(+) B cells traffic to the CNS in active multiple sclerosis","volume":"5","author":"Probstel","year":"2020","journal-title":"Sci Immunol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.cell.2018.11.035","article-title":"Recirculating intestinal IgA-producing cells regulate neuroinflammation via IL-10","volume":"176","author":"Rojas","year":"2019","journal-title":"Cell"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i29.8787","article-title":"Role of the normal gut microbiota","volume":"21","author":"Jandhyala","year":"2015","journal-title":"World J Gastroenterol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"3688","DOI":"10.3390\/ijms21103688","article-title":"Gut microbiota metabolism and interaction with food components","volume":"21","author":"Vernocchi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0812874106","article-title":"Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites","volume":"106","author":"Wikoff","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/116.9.1772","article-title":"Short-chain fatty acids in germfree mice and rats","volume":"116","author":"Hoverstad","year":"1986","journal-title":"J Nutr"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metab"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201848009","article-title":"Short-chain fatty acids: Bacterial messengers modulating the immunometabolism of T cells","volume":"49","author":"Luu","year":"2019","journal-title":"Eur J Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01390","article-title":"Alterations in circulating fatty acid are associated with gut microbiota dysbiosis and inflammation in multiple sclerosis","volume":"11","author":"Saresella","year":"2020","journal-title":"Front Immunol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.885031","article-title":"Microbial metabolites in multiple sclerosis: Implications for pathogenesis and treatment","volume":"16","author":"Duarte-Silva","year":"2022","journal-title":"Front Neurosci"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.661493","article-title":"Serum short-chain fatty acids and associations with inflammation in newly diagnosed patients with multiple sclerosis and healthy controls","volume":"12","author":"Olsson","year":"2021","journal-title":"Front Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"5244","DOI":"10.1038\/s41598-021-84881-8","article-title":"Associations of serum short-chain fatty acids with circulating immune cells and serum biomarkers in patients with multiple sclerosis","volume":"11","author":"Trend","year":"2021","journal-title":"Sci Rep"},{"key":"B87","doi-asserted-by":"publisher","first-page":"8837","DOI":"10.1038\/s41598-019-45311-y","article-title":"Bidirectional regulatory potentials of short-chain fatty acids and their G-protein-coupled receptors in autoimmune neuroinflammation","volume":"9","author":"Park","year":"2019","journal-title":"Sci Rep"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-021-01016-7","article-title":"Selected Clostridia strains from the human microbiota and their metabolite, butyrate, improve experimental autoimmune encephalomyelitis","volume":"18","author":"Calvo-Barreiro","year":"2021","journal-title":"Neurotherapeutics"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4106","article-title":"Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor","volume":"22","author":"Rothhammer","year":"2016","journal-title":"Nat Med"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.08.003","article-title":"Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22","volume":"39","author":"Zelante","year":"2013","journal-title":"Immunity"},{"key":"B91","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.immuni.2014.06.014","article-title":"Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4","volume":"41","author":"Venkatesh","year":"2014","journal-title":"Immunity"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1002\/glia.22643","article-title":"Adoptive transfer of cytokine-induced immunomodulatory adult microglia attenuates experimental autoimmune encephalomyelitis in DBA\/1 mice","volume":"62","author":"Zhang","year":"2014","journal-title":"Glia"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.chom.2021.07.013","article-title":"A bacterial bile acid metabolite modulates Treg activity through the nuclear hormone receptor NR4A1","volume":"29","author":"Li","year":"2021","journal-title":"Cell Host Microbe"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04480-z","article-title":"Human gut bacteria produce TauEta17-modulating bile acid metabolites","volume":"603","author":"Paik","year":"2022","journal-title":"Nature"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01853","article-title":"Bile acids activated receptors regulate innate immunity","volume":"9","author":"Fiorucci","year":"2018","journal-title":"Front Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901347","article-title":"The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis","volume":"183","author":"Mencarelli","year":"2009","journal-title":"J Immunol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neuroscience.2019.07.029","article-title":"Identification of altered metabolic pathways during disease progression in EAE mice via metabolomics and lipidomics","volume":"416","author":"Lee","year":"2019","journal-title":"Neuroscience"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1038\/nature11225","article-title":"Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-\/- mice","volume":"487","author":"Devkota","year":"2012","journal-title":"Nature"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1097\/mog.0000000000000057","article-title":"Bile acids and the gut microbiome","volume":"30","author":"Ridlon","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1172\/jci129401","article-title":"Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation","volume":"130","author":"Bhargava","year":"2020","journal-title":"J Clin Invest"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1524890113","article-title":"Obeticholic acid, a synthetic bile acid agonist of the farnesoid X receptor, attenuates experimental autoimmune encephalomyelitis","volume":"113","author":"Ho","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B102","doi-asserted-by":"publisher","first-page":"100522","DOI":"10.1016\/j.medj.2024.09.011","article-title":"Bile acid metabolites predict multiple sclerosis progression and supplementation is safe in progressive disease","volume":"6","author":"Ladakis","year":"2025","journal-title":"Med"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/137.10.2242","article-title":"Microbial and dietary factors are associated with the equol producer phenotype in healthy postmenopausal women1,2,3","volume":"137","author":"Bolca","year":"2007","journal-title":"J Nutr"},{"key":"B104","doi-asserted-by":"publisher","first-page":"2387794","DOI":"10.1007\/978-3-319-34034-0_16","article-title":"Game of microbes: the battle within \u2013 gut microbiota and multiple sclerosis","volume":"16","author":"Turner","year":"2024","journal-title":"Gut Microbes"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1128\/aem.71.1.214-219.2005","article-title":"Enantioselective synthesis of S-equol from dihydrodaidzein by a newly isolated anaerobic human intestinal bacterium","volume":"71","author":"Wang","year":"2005","journal-title":"Appl Environ Microbiol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2127446","article-title":"Dietary isoflavones alter gut microbiota and lipopolysaccharide biosynthesis to reduce inflammation","volume":"14","author":"Ghimire","year":"2022","journal-title":"Gut Microbes"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd4595","article-title":"Isoflavone diet ameliorates experimental autoimmune encephalomyelitis through modulation of gut bacteria depleted in patients with multiple sclerosis","volume":"7","author":"Jensen","year":"2021","journal-title":"Sci Adv"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1002\/iub.230","article-title":"Mammalian polyamine metabolism and function","volume":"61","author":"Pegg","year":"2009","journal-title":"IUBMB Life"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1002\/iub.230","article-title":"Polyamine metabolism and function","volume":"243","author":"Pegg","year":"1982","journal-title":"Am J Physiol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/130.5.1225","article-title":"The human gut bacteria Bacteroides thetaiotaomicron and Fusobacterium varium produce putrescine and spermidine in cecum of pectin-fed gnotobiotic rats","volume":"130","author":"Noack","year":"2000","journal-title":"J Nutr"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1080\/16512235.2017.1353881","article-title":"A wide diversity of bacteria from the human gut produces and degrades biogenic amines","volume":"28","author":"Pugin","year":"2017","journal-title":"Microb Ecol Health Dis"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00620.2008","article-title":"Polyamines regulate E-cadherin transcription through c-Myc modulating intestinal epithelial barrier function","volume":"296","author":"Liu","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00201.2007","article-title":"Polyamines are required for expression of Toll-like receptor 2 modulating intestinal epithelial barrier integrity","volume":"293","author":"Chen","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.16.7804","article-title":"The ornithine decarboxylase gene is a transcriptional target of c-Myc","volume":"90","author":"Bello-Fernandez","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"B115","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/medsci6010022","article-title":"Role of polyamines in immune cell functions","volume":"6","author":"Hesterberg","year":"2018","journal-title":"Med Sci (Basel)"},{"key":"B116","doi-asserted-by":"publisher","first-page":"4186","DOI":"10.1016\/j.cell.2021.06.007","article-title":"Polyamine metabolism is a central determinant of helper T cell lineage fidelity","volume":"184","author":"Puleston","year":"2021","journal-title":"Cell"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1186\/1423-0127-19-31","article-title":"Anti-inflammatory effects of spermidine in lipopolysaccharide-stimulated BV2 microglial cells","volume":"19","author":"Choi","year":"2012","journal-title":"J BioMed Sci"},{"key":"B118","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jaci.2020.04.037","article-title":"Regulating T-cell differentiation through the polyamine spermidine","volume":"147","author":"Carriche","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.10-6015","article-title":"Spermidine alleviates severity of murine experimental autoimmune encephalomyelitis","volume":"52","author":"Guo","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2016.71","article-title":"Spermidine alleviates experimental autoimmune encephalomyelitis through inducing inhibitory macrophages","volume":"23","author":"Yang","year":"2016","journal-title":"Cell Death Differ"},{"key":"B121","doi-asserted-by":"publisher","first-page":"4168","DOI":"10.1016\/j.cell.2021.05.045","article-title":"Metabolic modeling of single Th17 cells reveals regulators of autoimmunity","volume":"184","author":"Wagner","year":"2021","journal-title":"Cell"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abc4275","article-title":"De novo synthesis and salvage pathway coordinately regulate polyamine homeostasis and determine T cell proliferation and function","volume":"6","author":"Wu","year":"2020","journal-title":"Sci Adv"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00385","article-title":"Lactobacillus reuteri reduces the severity of experimental autoimmune encephalomyelitis in mice by modulating gut microbiota","volume":"10","author":"He","year":"2019","journal-title":"Front Immunol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2016.08.015","article-title":"Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial","volume":"36","author":"Kouchaki","year":"2017","journal-title":"Clin Nutr"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2020.1813532","article-title":"How oral probiotics affect the severity of an experimental model of progressive multiple sclerosis? Bringing commensal bacteria into the neurodegenerative process","volume":"12","author":"Mestre","year":"2020","journal-title":"Gut Microbes"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.623451","article-title":"Lactobacillus acidipiscis induced regulatory gamma delta T cells and attenuated experimental autoimmune encephalomyelitis","volume":"12","author":"Ren","year":"2021","journal-title":"Front Immunol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"906","DOI":"10.3390\/cells9040906","article-title":"A commercial probiotic induces tolerogenic and reduces pathogenic responses in experimental autoimmune encephalomyelitis","volume":"9","author":"Calvo-Barreiro","year":"2020","journal-title":"Cells"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01662","article-title":"Gut microbiota interventions with Clostridium butyricum and norfloxacin modulate immune response in experimental autoimmune encephalomyelitis mice","volume":"10","author":"Chen","year":"2019","journal-title":"Front Immunol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.578648","article-title":"Human commensal Prevotella histicola ameliorates disease as effectively as interferon-beta in the experimental autoimmune encephalomyelitis","volume":"11","author":"Shahi","year":"2020","journal-title":"Front Immunol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/brainsci10020126","article-title":"Streptococcus thermophilus ST285 alters pro-inflammatory to anti-inflammatory cytokine secretion against multiple sclerosis peptide in mice","volume":"10","author":"Dargahi","year":"2020","journal-title":"Brain Sci"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.07.031","article-title":"Human gut-derived commensal bacteria suppress CNS inflammatory and demyelinating disease","volume":"20","author":"Mangalam","year":"2017","journal-title":"Cell Rep"},{"key":"B132","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/14737175.2019.1555473","article-title":"Microbial monotherapy with Prevotella histicola for patients with multiple sclerosis","volume":"19","author":"Mangalam","year":"2019","journal-title":"Expert Rev Neurother"},{"key":"B133","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1177\/1352458517736377","article-title":"Safety and efficacy of helminth treatment in relapsing-remitting multiple sclerosis: results of the HINT 2 clinical trial","volume":"25","author":"Fleming","year":"2019","journal-title":"Mult Scler"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1017\/S0022149X11000460","article-title":"Immune monitoring of Trichuris suis egg therapy in multiple sclerosis patients","volume":"86","author":"Benzel","year":"2012","journal-title":"J Helminthol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1177\/1352458511398054","article-title":"Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study","volume":"17","author":"Fleming","year":"2011","journal-title":"Mult Scler"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14515","article-title":"Letter: what gastroenterologists should know about VSL#3","volume":"47","author":"De Simone","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25244","article-title":"A probiotic modulates the microbiome and immunity in multiple sclerosis","volume":"83","author":"Tankou","year":"2018","journal-title":"Ann Neurol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41430-018-0135-9","article-title":"A review of probiotic supplementation in healthy adults: helpful or hype","volume":"73","author":"Khalesi","year":"2019","journal-title":"Eur J Clin Nutr"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114510002746","article-title":"Tolerance and safety of the potentially probiotic strain Lactobacillus rhamnosus PRSF-L477: a randomised, double-blind placebo-controlled trial in healthy volunteers","volume":"104","author":"Wind","year":"2010","journal-title":"Br J Nutr"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1080\/1028415x.2020.1758887","article-title":"Effects of long-term administration of multi-strain probiotic on circulating levels of BDNF, NGF, IL-6 and mental health in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial","volume":"25","author":"Rahimlou","year":"2022","journal-title":"Nutr Neurosci"},{"key":"B141","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11940-021-00693-1","article-title":"Gut microbiome as potential therapeutics in multiple sclerosis","volume":"23","author":"Zhu","year":"2021","journal-title":"Curr Treat Options Neurol"},{"key":"B142","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.100525","article-title":"Prebiotics, probiotics and synbiotic for bone health","volume-title":"Prebiotics and Probiotics - From Food to Health","author":"Lilian Ilesanmi-Oyelere","year":"2022"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-017-0339-3","article-title":"Prebiotics, bone and mineral metabolism","volume":"102","author":"Whisner","year":"2018","journal-title":"Calcif Tissue Int"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1111\/ane.13045","article-title":"Short-chain fatty acids and gut microbiota in multiple sclerosis","volume":"139","author":"Melbye","year":"2019","journal-title":"Acta Neurol Scand"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1108\/nfs-01-2019-0001","article-title":"Dietary intake of energy and fiber in MS patients; an approach to prebiotics role","volume":"49","author":"Moravejolahkami","year":"2019","journal-title":"Nutr Food Sci"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0173032","article-title":"The dual role of short fatty acid chains in the pathogenesis of autoimmune disease models","volume":"12","author":"Mizuno","year":"2017","journal-title":"PloS One"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2009.07487.x","article-title":"Neuroprotective effects of naturally occurring polyphenols on quinolinic acid-induced excitotoxicity in human neurons","volume":"277","author":"Braidy","year":"2010","journal-title":"FEBS J"},{"key":"B148","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.72322","volume-title":"Polyphenols","author":"Wong","year":"2018"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.10.5797","article-title":"Highly oligomeric procyanidins ameliorate experimental autoimmune encephalomyelitis via suppression of Th1 immunity","volume":"176","author":"Miyake","year":"2006","journal-title":"J Immunol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2020.1857515","article-title":"Pomegranate peel extract ameliorates the severity of experimental autoimmune encephalomyelitis via modulation of gut microbiota","volume":"12","author":"Lu","year":"2020","journal-title":"Gut Microbes"},{"key":"B151","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1136\/jnnp-2016-314490","article-title":"Complementary and alternative treatments of multiple sclerosis: a review of the evidence from 2001 to 2016","volume":"89","author":"Claflin","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd004192.pub4","article-title":"Dietary interventions for multiple sclerosis-related outcomes","volume":"5","author":"Parks","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"B153","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.cmet.2018.05.006","article-title":"Intermittent fasting confers protection in CNS autoimmunity by altering the gut microbiota","volume":"27","author":"Cignarella","year":"2018","journal-title":"Cell Metab"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.101403","article-title":"Randomized-controlled trial of a modified Mediterranean dietary program for multiple sclerosis: a pilot study","volume":"36","author":"Katz Sand","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2022-329074","article-title":"Phase II study of ketogenic diets in relapsing multiple sclerosis: safety, tolerability and potential clinical benefits","volume":"93","author":"Brenton","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000001102","article-title":"Impact of dietary intervention on serum neurofilament light chain in multiple sclerosis","volume":"9","author":"Bock","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.101921","article-title":"Is diet associated with physical capacity and fatigue in persons with multiple sclerosis? -Results from a pilot study","volume":"40","author":"Albrechtsen","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1177\/20552173211035399","article-title":"Impact of the Swank and Wahls elimination dietary interventions on fatigue and quality of life in relapsing-remitting multiple sclerosis: the WAVES randomized parallel-arm clinical trial","volume":"7","author":"Wahls","year":"2021","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.1022728","article-title":"Association between improved metabolic risk factors and perceived fatigue during dietary intervention trial in relapsing-remitting multiple sclerosis: a secondary analysis of the WAVES trial","volume":"13","author":"Villa","year":"2022","journal-title":"Front Neurol"},{"key":"B160","doi-asserted-by":"publisher","first-page":"103557","DOI":"10.2139\/ssrn.3783095","article-title":"Alterations of the gut mycobiome in patients with MS","volume":"71","author":"Shah","year":"2021","journal-title":"eBioMedicine"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103798","article-title":"Alterations of host-gut microbiome interactions in multiple sclerosis","volume":"76","author":"Cantoni","year":"2022","journal-title":"EBioMedicine"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1711233114","article-title":"Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice","volume":"114","author":"Berer","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.103829","article-title":"The metabolic potential of the paediatric-onset multiple sclerosis gut microbiome","volume":"63","author":"Mirza","year":"2022","journal-title":"Multiple Sclerosis Related Disord"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0264556","article-title":"Multiple sclerosis patients have an altered gut mycobiome and increased fungal to bacterial richness","volume":"17","author":"Yadav","year":"2022","journal-title":"PloS One"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1177\/17562864241306565","article-title":"Immunotherapy-mediated modulation of the gut microbiota in multiple sclerosis and associations with diet and clinical response\u2014the effect of dimethyl fumarate therapy","volume":"18","author":"Staun-Ram","year":"2025","journal-title":"Ther Adv Neurological Disord"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.15698\/mic2024.04.819","article-title":"The effect of multiple sclerosis therapy on gut microbiota dysbiosis: a longitudinal prospective study","volume":"11","author":"Paraschiv","year":"2024","journal-title":"Microb Cell"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-12107-0","article-title":"Disease-modifying therapies used to treat multiple sclerosis and the gut microbiome: a systematic review","volume":"271","author":"Tsai","year":"2024","journal-title":"J Neurol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1858047\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:13:54Z","timestamp":1782893634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1858047\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":167,"alternative-id":["10.3389\/fimmu.2026.1858047"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1858047","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"article-number":"1858047"}}